Attention Deficit Hyperactivity DisorderNCT01477125
Working Memory Training in Adults With ADHD
A study testing Flex working memory training in people with Attention Deficit Hyperactivity Disorder, run by Karolinska Institutet at 1 site in Sweden.
Trial summary
The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50). Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Attention Deficit Hyperactivity Disorder
- What is being tested?
- Flex working memory training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 102 participants
- Where
- 1 siteSweden
- Study dates
- Nov 2013to 15 Jun 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Confirmed ADHD according to DSM-IV criteria; ADHD combined type, ADHD inattentive type or ADHD UNS, primarily inattentive type.
- Unmedicated for ADHD during the course of the trial, or being under stable ADHD medication for at least one month at baseline visit and without any planned changes in medication until post-study assessments have taken place.
Who cannot join
- Previous participation in computerised working memory training (completed training).
- Any psychiatric disorder that in the judgment of the investigator, may interfere with study participation and/or study assessments, also including current substance abuse.
- Participation in psychological treatment addressing ADHD during the course of the 5-week training period (psychoeducation is accepted).
- Initiation of psychological treatment for coexistent disorders during the course of the study (treatment already ongoing at baseline visit is accepted if there are no planned changes during the 5-week training period).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Computerised Working Memory Training in Adults With ADHD: A Randomised Controlled Trial
The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50).
Read the detailed description
The primary aim is to evaluate whether 5 weeks of computerised working memory training improves working memory capacity. Secondary aims are to explore whether improvements in working memory capacity will be transferred to improvements in learning abilities and fluid intelligence. Also, far transfer effects on executive functioning, ADHD symptoms, psychosocial functioning and quality of life will be explored. Finally, it will also be assessed to what extent improvements gained from 5 weeks of working memory training will be maintained 3 and 6 months post-study, respectively.
- Conditions
- Attention Deficit Hyperactivity Disorder
- Being tested
- Flex working memory training
- Keywords
- adhd, adults, working memory, training, RCT
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Flex working memory trainingBehavioural
30-40 minutes of working memory training, 5 days a week for 5 weeks
| Study group | Role | What they receive |
|---|---|---|
| Flex working memory training | Experimental | 30-40 minutes of working memory training, 5 days a week for 5 weeks Receives: Behavioral: Flex working memory training |
| Control version of Flex | Placebo comparator | 30-40 minutes of training with a control version of Flex, 5 days a week for 5 weeks. Receives: Behavioral: Flex working memory training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in a composite measure of working memory capacity
The composite measure of working memory capacity comprises the sum score of:
- Digit Span score (forwards/backwards)
- Span Board score (forwards/backwards)
- Arithmetics score
- Spatial Working Memory score
Measured: Baseline and 7 weeks
Secondary outcomes (13)
Change in a composite measure of working memory capacity
The composite measure of working memory capacity will be assessed in a 6-month follow-up conducted at week 31 post-baseline, equivalent to week 24 post-intervention, to assess retention of any training-related improvements.
Measured: Baseline and 31 weeks
Change in Digit Span Forwards/Backwards score
Evaluating changes in both Digit Span forwards and backwards scores, as measures of simple verbal working memory capacity.
Measured: Baseline, 7 and 31 weeks
Change in Span Board Forwards/Backwards score
Evaluating changes in both Span Board forwards and backwards scores as measures of simple visuo-spatial working memory capacity.
Measured: Baseline, 7 and 31 weeks
Change in Arithmetics score
Evaluating change in Arithmetics score, as a measure of complex verbal working memory capacity as well as of mathematics ability.
Measured: Baseline, 7 and 31 weeks
Change in Spatial Working Memory score
Evaluating change in Spatial Working Memory score as a measure of complex visuo-spatial working memory capacity.
Measured: Baseline, 7 and 31 weeks
Change in Qbtest scores
Evaluating changes in Qbtest, a computerised CPT that in addition to measuring inattention and impulsivity also captures motor activity by an IR device during performance of the CPT.
Measured: Baseline, 7 and 31 weeks
Change in Raven´s Standard Progressive Matrices score
Evaluating change in score of a short version of Raven´s Standard Progressive Matrices, as a measure of fluid intelligence.
Measured: Baseline, 7 and 31 weeks
Change in Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
Evaluating changes in ADHD symptoms by self-reported and informant-reported (significant other) versions of ASRS-v1.1, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Measured: Baseline, 7, 19, and 31 weeks
Change in Sheehan Disability Scale (SDS)
Evaluating changes in psychosocial functioning by the self-reported SDS conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Measured: Baseline, 7, 19, and 31 weeks
Change in EuroQol- 5 Dimensions (EQ-5D) questionnaire
Evaluating change in health-related quality of life by the self-reported generic QoL questionnaire EQ-5D, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Measured: Baseline, 7, 19, and 31 weeks
Change in Adult ADHD Quality of Life Measure (AAQoL)
Evaluating change in health-related quality of life by the self-reported ADHD specific QoL measure AAQoL, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Measured: Baseline, 7, 19, and 31 weeks
Montgomery Åsberg Depression Rating Scale-Self report (MADRS-S)
Evaluating if depressive symptoms during the training period, as measured by the self-reported MADRS-S will influence adherence to and results of the working memory training.
Measured: Baseline and 7 weeks
Adverse events
All adverse events that occurred during the course of the 5-week intervention will be collected as part of the post-intervention assessments at week 7.
Measured: Baseline and 7 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Nov 2011 (estimated)
- Study startNov 2013
- Primary completion15 Dec 2017
- Study completion15 Jun 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention Deficit Hyperactivity DisorderStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 102 participants (actual)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Collaborators
- Region Stockholm, Swedish Prison and Probation Services, The Söderströmska-Königska Foundation
- Responsible party
- Principal investigator, Ylva Ginsberg, MD, PhD, Karolinska Institutet
- Investigators
- Ylva Ginsberg, MD, PhD, Principal investigator, Karolinska InstitutetHenrik Larsson, PhD, Study director, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01477125
- Sponsor's protocol ID
- X002
- Other IDs
- DAT-NSP, DAT-KV
- Status last verified
- Sep 2020
- First submitted
- 15 Nov 2011
- Last updated
- 3 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Computerised Working Memory Training in Adults With ADHD: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT01477125
- Acronym / sponsor ID
- X002
- Conditions
- Attention Deficit Hyperactivity Disorder
- Keywords
- adhd, adults, working memory, training, RCT
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 102 participants (actual)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Collaborators
- Region Stockholm, Swedish Prison and Probation Services, The Söderströmska-Königska Foundation
- Study start
- Nov 2013
- Primary completion
- 15 Dec 2017 (actual)
- Study completion
- 15 Jun 2018 (actual)
- First posted
- 22 Nov 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50).
Detailed description
The primary aim is to evaluate whether 5 weeks of computerised working memory training improves working memory capacity. Secondary aims are to explore whether improvements in working memory capacity will be transferred to improvements in learning abilities and fluid intelligence. Also, far transfer effects on executive functioning, ADHD symptoms, psychosocial functioning and quality of life will be explored. Finally, it will also be assessed to what extent improvements gained from 5 weeks of working memory training will be maintained 3 and 6 months post-study, respectively.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Flex working memory training | Experimental | Behavioral: Flex working memory training30-40 minutes of working memory training, 5 days a week for 5 weeks |
| Control version of Flex | Placebo comparator | Behavioral: Flex working memory training30-40 minutes of training with a control version of Flex, 5 days a week for 5 weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Confirmed ADHD according to DSM-IV criteria; ADHD combined type, ADHD inattentive type or ADHD UNS, primarily inattentive type.
- Unmedicated for ADHD during the course of the trial, or being under stable ADHD medication for at least one month at baseline visit and without any planned changes in medication until post-study assessments have taken place.
Key exclusion criteria (4 listed)
- Previous participation in computerised working memory training (completed training).
- Any psychiatric disorder that in the judgment of the investigator, may interfere with study participation and/or study assessments, also including current substance abuse.
- Participation in psychological treatment addressing ADHD during the course of the 5-week training period (psychoeducation is accepted).
- Initiation of psychological treatment for coexistent disorders during the course of the study (treatment already ongoing at baseline visit is accepted if there are no planned changes during the 5-week training period).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Flex working memory training30-40 minutes of working memory training, 5 days a week for 5 weeks | Behavioural | Control version of Flex, Flex working memory training |
Primary outcome
Change in a composite measure of working memory capacity
Time frame: Baseline and 7 weeks
The composite measure of working memory capacity comprises the sum score of: * Digit Span score (forwards/backwards) * Span Board score (forwards/backwards) * Arithmetics score * Spatial Working Memory score
13 secondary outcomes
Change in a composite measure of working memory capacity
Time frame: Baseline and 31 weeks
Change in Digit Span Forwards/Backwards score
Time frame: Baseline, 7 and 31 weeks
Change in Span Board Forwards/Backwards score
Time frame: Baseline, 7 and 31 weeks
Change in Arithmetics score
Time frame: Baseline, 7 and 31 weeks
Change in Spatial Working Memory score
Time frame: Baseline, 7 and 31 weeks
Change in Qbtest scores
Time frame: Baseline, 7 and 31 weeks
Change in Raven´s Standard Progressive Matrices score
Time frame: Baseline, 7 and 31 weeks
Change in Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
Time frame: Baseline, 7, 19, and 31 weeks
Change in Sheehan Disability Scale (SDS)
Time frame: Baseline, 7, 19, and 31 weeks
Change in EuroQol- 5 Dimensions (EQ-5D) questionnaire
Time frame: Baseline, 7, 19, and 31 weeks
Change in Adult ADHD Quality of Life Measure (AAQoL)
Time frame: Baseline, 7, 19, and 31 weeks
Montgomery Åsberg Depression Rating Scale-Self report (MADRS-S)
Time frame: Baseline and 7 weeks
Adverse events
Time frame: Baseline and 7 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2020.
Related trials for Attention Deficit Hyperactivity Disorder
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
RecruitingObservational study
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Disruptive Behavior Disorders, Conduct Disorder
RecruitingPhase 2
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
Attention Deficit Disorder With Hyperactivity (ADHD)
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
RecruitingObservational study
Pharmacogenomics of Stimulant Treatment Response
Attention-Deficit/ Hyperactivity Disorder (ADHD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ylva Ginsberg, MD, PhD principal investigator
Karolinska Institutet
Henrik Larsson, PhD study director
Karolinska Institutet
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Flex working memory training in people with Attention Deficit Hyperactivity Disorder, run by Karolinska Institutet at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in a composite measure of working memory capacity (time frame: Baseline and 7 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2020.